Speed isn't just the pulse of the market. Sometimes it's the heartbeat of a regulatory letter.
Last week, a document landed on the SEC's desk that didn't come from a Wall Street law firm or a syndicate of investment banks. It came from HPC and trade[XYZ]—two crypto-native entities pushing a product that could reshape how we price IPOs before they even hit the public market.
The product? IPOPs—Initial Pre-IPO Perpetuals. Think of them as synthetic perpetual contracts that track the price of a company before its IPO. No equity. No voting rights. Just pure price discovery, traded on Hyperliquid's order book.
And here's the kicker: five IPOP markets have already run their full lifecycle on Hyperliquid, and the data shows that IPO prices were consistently set 10.8% to 38.4% below the IPOP market price the day before listing. That's a massive signal that the traditional IPO pricing mechanism is leaving money on the table—or at least that's what the letter argues.
Context: Why Now and Why This Matters
The IPO market is an opaque beast. Retail investors get crumbs. Whales get allocations. The pop on day one is often a function of underpricing, not fundamental value. IPOPs propose a solution: a continuous, public, and transparent price discovery mechanism that runs for weeks before the IPO.
Hyperliquid is already the go-to for high-throughput perpetuals. It's an order-book DEX that matches the speed of centralized exchanges while keeping custody on-chain. The IPOP product is an extension of that tech—same perpetual swap formula, different termination event (the IPO date).
But here's the catch: the data in the letter comes from HPC and trade[XYZ] themselves. There's no independent audit. No third-party verification. It's a self-reported success story, and in crypto, we've learned that self-reported data is often the first casualty of a bull run.
Core: The Numbers and the Narrative
Let's dig into the hard data. The letter claims that over five IPOP markets, the opening price on the first day of trading was within 1.2% of the IPOP final settlement price. That's impressive if true. But it's also a small sample size. Five markets. Five companies. Not enough to prove statistical significance, but enough to start a conversation.
From my own experience during the DeFi summer sprint, I've seen protocols launch with 72-hour hype cycles that crumble when the data is stress-tested. The IPOP model is different because it's not a liquidity mine—it's a derivative market. The incentives are cleaner: traders bet on price direction, not on token emissions.
But the technical gap is real. The letter doesn't specify how the settlement price is determined. Is it the IPO price? The first day closing price? An oracle median? That ambiguity is a red flag. If the settlement source is centralized, the entire product is a black box.
And then there's the regulation angle. The letter explicitly asks the SEC for guidance on classification, disclosure, listing standards, market integrity, and investor access. This is not a declaration of victory—it's a plea for clarity. HPC and trade[XYZ] are betting that the SEC will treat IPOPs as a commodity derivative rather than a security-based swap. If they're wrong, the product could be shut down for US users.
Contrarian: The Unreported Angle
Everyone is focused on the price discovery narrative. But the real story is about information asymmetry.
IPOPs allow trading on a company's value weeks before the IPO. Who has the best information? The company insiders, the venture capitalists, the underwriters. They know the financials, the roadshow feedback, the demand. They could trade on that information before the public even sees the S-1.
This is not a decentralization story—it's a potential insider trading nightmare.
The SEC's biggest concern won't be whether IPOPs are efficient. It will be whether they are fair. And the answer right now is: we don't know, because the KYC/AML framework is not disclosed.
Another blind spot: trade[XYZ] is likely the market maker and liquidity provider for these IPOP markets. Their incentive to push for regulatory approval is not philanthropic—it's commercial. They want to scale their business. The letter is a business development document disguised as a policy proposal.
We didn't need a PhD to see this coming. The same playbook played out with prediction markets, with event contracts, with every synthetic asset. The crypto industry always leads with innovation and asks for permission later. IPOPs are just the latest iteration.
Takeaway: What to Watch Next
This is not a breakthrough. It's a beta test in full view of the regulator. The next 60 days are critical. If the SEC issues a no-action letter or a favorable guidance, expect a flood of IPOP markets on Hyperliquid and copycats on other platforms. If the SEC stays silent or pushes back, the product will likely retreat to non-US markets.
Exchange leads see the wave before it breaks. The wave here is regulatory clarity for synthetic pre-IPO derivatives. But the current is still unpredictable.
From chaos to clarity: tracking the summer of IPOPs. The question isn't whether the product works—it's whether the SEC will let it work for everyone.